港股异动 | 开拓药业-B(09939)涨超5% 拟折让15.03%发行认购股份筹资 用于KX-826 III期临床试验
KINTOR PHARMAKINTOR PHARMA(HK:09939) 智通财经网·2025-11-14 03:32

Core Viewpoint - 开拓药业-B's stock price increased by over 5%, reaching HKD 2.15, with a trading volume of HKD 5.5445 million [1] Group 1: Company Announcement - 开拓药业-B announced plans to issue 30.4875 million subscription shares to 华圆管理咨询(香港)有限公司 at a subscription price of HKD 1.64 per share, representing a discount of approximately 15.03% compared to the last trading price of HKD 1.93 [1] - The net proceeds from the subscription are expected to be approximately HKD 49.78 million, which will be used for the company's general operating funds and the Phase III clinical trial of KX-826 [1]